Immediate Impact
50 standout
Citing Papers
Therapeutic advances in rheumatoid arthritis
2024 Standout
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
2023 Standout
Works of Rüdiger Müller being referenced
Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland
2020
Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Rüdiger Müller | 312 | 207 | 53 | 106 | 26 | 567 | |
| R H Withrington | 278 | 138 | 54 | 74 | 20 | 508 | |
| Tim Holbrook | 128 | 140 | 84 | 38 | 33 | 602 | |
| Tsivia Tauber | 115 | 90 | 34 | 115 | 28 | 465 | |
| Marco Krasselt | 186 | 128 | 88 | 51 | 37 | 466 | |
| G Danieli | 210 | 156 | 101 | 68 | 31 | 572 | |
| Ilan Asher | 175 | 217 | 58 | 22 | 36 | 553 | |
| Ibrahim Almaghlouth | 189 | 215 | 36 | 94 | 37 | 582 | |
| Ray Armstrong | 230 | 114 | 40 | 75 | 32 | 519 | |
| Bóris Afonso Cruz | 403 | 96 | 45 | 254 | 38 | 647 | |
| Hilde Carlier | 362 | 372 | 79 | 154 | 26 | 614 |
All Works
Login with ORCID to disown or claim papers
Loading papers...